logo

Altimmune Inc. (ALT)



Trade ALT now with
  Date
  Headline
8/31/2018 8:01:49 AM Altimmune Announces Initial Single-Dose Data From Its NasoShield Phase 1 Study
7/12/2018 8:08:29 AM Altimmune Restructures Financing Agreement With Majority Of Remaining Series B Investors
7/10/2018 8:06:04 AM Altimmune Appoints Mitchel Sayare As Executive Chairman Of Board
3/27/2018 8:09:43 AM Altimmune Announces Positive Data From Its Phase 2a Study Of NasoVAX Intranasal Influenza Vaccine
1/23/2018 8:04:38 AM Altimmune Reports Notice Of Allowance On Patent Covering Use Of NasoShield In The U.S.
1/3/2018 8:05:17 AM Altimmune Elects Mitchel Sayare As Chairman Of Board
  
 
>